A Multicentre, Randomized, Double-Blind, Placebo Controlled, Parallel group, Phase 3 Study to Evaluate the Efficacy and Safety of Tezepelumab in Adults and Adolescents with Severe Uncontrolled Asthma (NAVIGATOR).

  • Gillman, Andrew, (Primary Chief Investigator (PCI))
  • Hazard, Anita (Project Manager)
  • Thompson, Katherine, (Project Manager)

Project: Research

StatusActive
Effective start/end date2/12/19 → 31/12/20
View all
View less

Keywords

  • Respiratory medicine
  • Asthma
  • Clinical trial